SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2is7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LII_A_ADNA699_2
(ADENOSINE KINASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 4 SER A 201
LEU A 170
TYR A 198
GLY A 203
None
1.43A 1liiA-2is7A:
1.8
1liiA-2is7A:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1LIN_A_TFPA156_1
(CALMODULIN)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 8 ILE A  74
LEU A  99
ILE A  58
VAL A  31
ILE A  42
None
1.45A 1linA-2is7A:
undetectable
1linA-2is7A:
17.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1S2A_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 12 TRP A  79
HIS A 110
GLU A 185
TYR A 209
SER A 210
None
2CL  A 317 ( 3.8A)
None
NAP  A 316 (-3.2A)
NAP  A 316 (-2.7A)
0.21A 1s2aA-2is7A:
46.4
1s2aA-2is7A:
48.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FCN_B_DVAB35_0
(UBIQUITIN)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 6 ARG A 255
GLN A 192
GLU A 193
ILE A 196
None
1.01A 2fcnA-2is7A:
undetectable
2fcnB-2is7A:
undetectable
2fcnA-2is7A:
12.50
2fcnB-2is7A:
12.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2INE_A_PACA317_0
(ALDOSE REDUCTASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 5 TRP A  20
VAL A  47
TYR A  48
HIS A 110
TRP A 111
2CL  A 317 ( 3.4A)
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 ( 4.0A)
0.10A 2ineA-2is7A:
55.3
2ineA-2is7A:
99.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ISF_A_PACA317_0
(ALDOSE REDUCTASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 5 TRP A  20
VAL A  47
TYR A  48
HIS A 110
TRP A 111
2CL  A 317 ( 3.4A)
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 ( 4.0A)
0.17A 2isfA-2is7A:
55.0
2isfA-2is7A:
98.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q83_B_ADNB2_1
(YTAA PROTEIN)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 6 CYH A 199
PRO A 179
LEU A 108
ILE A 158
None
1.01A 2q83B-2is7A:
undetectable
2q83B-2is7A:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_B_TRPB1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 GLY A  55
ILE A  42
VAL A  31
VAL A  27
None
0.68A 3fi0B-2is7A:
undetectable
3fi0B-2is7A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_G_TRPG1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 GLY A  55
ILE A  42
VAL A  31
VAL A  27
None
0.73A 3fi0G-2is7A:
undetectable
3fi0G-2is7A:
20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_I_TRPI1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 GLY A  55
ILE A  42
VAL A  31
VAL A  27
None
0.74A 3fi0I-2is7A:
undetectable
3fi0I-2is7A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_Q_TRPQ1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 GLY A  55
ILE A  42
VAL A  31
VAL A  27
None
0.69A 3fi0Q-2is7A:
undetectable
3fi0Q-2is7A:
20.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R43_A_ID8A332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 12 TYR A  48
TRP A  79
HIS A 110
ASN A 160
TYR A 209
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
0.29A 3r43A-2is7A:
45.8
3r43A-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R58_A_NPSA332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 10 TYR A  48
HIS A 110
ASN A 160
TYR A 209
PRO A 310
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
None
0.41A 3r58A-2is7A:
44.7
3r58A-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R6I_A_JMSA332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 12 TYR A  48
TRP A  79
HIS A 110
ASN A 160
TYR A 209
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
0.29A 3r6iA-2is7A:
44.5
3r6iA-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R8G_A_IZPA409_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 9 TYR A  48
HIS A 110
ASN A 160
TYR A 209
PRO A 310
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
None
0.42A 3r8gA-2is7A:
44.6
3r8gA-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R94_A_FLRA332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 12 TYR A  48
HIS A 110
ASN A 160
TYR A 209
PRO A 310
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
None
0.48A 3r94A-2is7A:
44.4
3r94A-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RX3_A_SUZA317_1
(ALDOSE REDUCTASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
10 / 10 TRP A  20
VAL A  47
TYR A  48
HIS A 110
TRP A 111
PHE A 122
TRP A 219
CYH A 298
LEU A 300
SER A 302
2CL  A 317 ( 3.4A)
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 ( 4.0A)
2CL  A 317 ( 4.9A)
None
2CL  A 317 (-3.5A)
None
None
0.50A 3rx3A-2is7A:
54.2
3rx3A-2is7A:
99.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S3G_A_TLTA317_1
(ALDOSE REDUCTASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
7 / 7 TRP A  20
TYR A  48
HIS A 110
TRP A 111
PHE A 122
TRP A 219
CYH A 298
2CL  A 317 ( 3.4A)
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 ( 4.0A)
2CL  A 317 ( 4.9A)
None
2CL  A 317 (-3.5A)
0.34A 3s3gA-2is7A:
54.1
3s3gA-2is7A:
99.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U2C_A_SUZA2001_1
(ALDOSE REDUCTASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
9 / 9 TRP A  20
VAL A  47
TYR A  48
HIS A 110
TRP A 111
PHE A 122
TRP A 219
CYH A 298
SER A 302
2CL  A 317 ( 3.4A)
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 ( 4.0A)
2CL  A 317 ( 4.9A)
None
2CL  A 317 (-3.5A)
None
0.20A 3u2cA-2is7A:
54.6
3u2cA-2is7A:
98.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UG8_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 12 ASN A 160
TYR A 209
SER A 210
SER A 214
PRO A 310
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
NAP  A 316 (-2.7A)
NAP  A 316 (-2.7A)
None
0.90A 3ug8A-2is7A:
44.6
3ug8A-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UG8_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
7 / 12 TYR A  48
TRP A  79
HIS A 110
ASN A 160
TYR A 209
SER A 210
PRO A 310
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
NAP  A 316 (-2.7A)
None
0.57A 3ug8A-2is7A:
44.6
3ug8A-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UGR_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 12 TRP A  79
HIS A 110
TYR A 209
SER A 210
SER A 214
None
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.2A)
NAP  A 316 (-2.7A)
NAP  A 316 (-2.7A)
0.79A 3ugrA-2is7A:
44.9
3ugrA-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UGR_A_IMNA2001_2
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 7 TYR A  48
ASN A 160
GLU A 185
PRO A 310
2CL  A 317 ( 4.5A)
NAP  A 316 (-3.4A)
None
None
0.59A 3ugrA-2is7A:
44.9
3ugrA-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3V35_A_NTIA317_1
(ALDOSE REDUCTASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
8 / 8 TRP A  20
VAL A  47
TRP A  79
HIS A 110
TRP A 111
PHE A 122
PRO A 218
TRP A 219
2CL  A 317 ( 3.4A)
2CL  A 317 (-4.2A)
None
2CL  A 317 ( 3.8A)
NAP  A 316 ( 4.0A)
2CL  A 317 ( 4.9A)
None
None
0.34A 3v35A-2is7A:
54.0
3v35A-2is7A:
99.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3V35_A_NTIA317_1
(ALDOSE REDUCTASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 TRP A  79
HIS A 110
TRP A 111
PHE A 115
None
2CL  A 317 ( 3.8A)
NAP  A 316 ( 4.0A)
None
1.38A 3v35A-2is7A:
54.0
3v35A-2is7A:
99.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ1_B_NPSB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 VAL A  47
TYR A  48
TRP A  79
HIS A 110
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
0.43A 4jq1B-2is7A:
46.5
4jq1B-2is7A:
49.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ4_A_IMNA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 10 VAL A  47
TYR A  48
HIS A 110
TYR A 209
LEU A 300
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.2A)
None
0.67A 4jq4A-2is7A:
46.6
4jq4A-2is7A:
49.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ4_B_IMNB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 10 TYR A  48
HIS A 110
ASN A 160
TYR A 209
LEU A 300
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
None
0.57A 4jq4B-2is7A:
46.2
4jq4B-2is7A:
49.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQA_B_ID8B401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 9 VAL A  47
TYR A  48
TRP A  79
HIS A 110
LEU A 300
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
None
0.86A 4jqaB-2is7A:
46.8
4jqaB-2is7A:
49.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTR_A_IBPA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 VAL A  47
TRP A  79
HIS A 110
LEU A 300
2CL  A 317 (-4.2A)
None
2CL  A 317 ( 3.8A)
None
1.01A 4jtrA-2is7A:
46.7
4jtrA-2is7A:
49.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTR_A_IBPA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 VAL A  47
TYR A  48
TRP A  79
HIS A 110
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
0.22A 4jtrA-2is7A:
46.7
4jtrA-2is7A:
49.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTR_B_IZPB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 6 VAL A  47
TYR A  48
TRP A  79
HIS A 110
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
0.22A 4jtrB-2is7A:
46.8
4jtrB-2is7A:
49.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_C_STRC601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 5 ILE A  35
ARG A   3
ASP A 105
VAL A  54
None
1.08A 4nkxC-2is7A:
undetectable
4nkxC-2is7A:
19.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_D_STRD601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 5 ILE A  35
ARG A   3
ASP A 105
VAL A  54
None
1.10A 4nkxD-2is7A:
undetectable
4nkxD-2is7A:
19.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TZC_D_EF2D505_1
(PROTEIN CEREBLON)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 8 THR A 140
HIS A 306
TRP A  79
PHE A 122
None
None
None
2CL  A 317 ( 4.9A)
1.47A 4tzcB-2is7A:
0.0
4tzcD-2is7A:
0.0
4tzcB-2is7A:
15.46
4tzcD-2is7A:
15.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WEV_X_SUZX402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER B10)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
6 / 10 TRP A  20
TYR A  48
HIS A 110
PHE A 122
TRP A 219
CYH A 298
2CL  A 317 ( 3.4A)
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
2CL  A 317 ( 4.9A)
None
2CL  A 317 (-3.5A)
1.01A 4wevX-2is7A:
50.6
4wevX-2is7A:
70.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4WEV_X_SUZX402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER B10)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
7 / 10 TRP A  20
VAL A  47
TYR A  48
HIS A 110
TRP A 219
CYH A 298
LEU A 300
2CL  A 317 ( 3.4A)
2CL  A 317 (-4.2A)
2CL  A 317 ( 4.5A)
2CL  A 317 ( 3.8A)
None
2CL  A 317 (-3.5A)
None
0.44A 4wevX-2is7A:
50.6
4wevX-2is7A:
70.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YVP_B_GBMB402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C1)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 12 TYR A  48
TRP A  79
HIS A 110
ASN A 160
LEU A 300
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
None
1.07A 4yvpB-2is7A:
47.7
4yvpB-2is7A:
48.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YVV_A_GBMA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 9 TYR A  48
TRP A  79
HIS A 110
ASN A 160
TYR A 209
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
NAP  A 316 (-3.2A)
0.27A 4yvvA-2is7A:
46.5
4yvvA-2is7A:
48.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YVX_A_GMRA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
5 / 12 TYR A  48
TRP A  79
HIS A 110
ASN A 160
SER A 302
2CL  A 317 ( 4.5A)
None
2CL  A 317 ( 3.8A)
NAP  A 316 (-3.4A)
None
0.90A 4yvxA-2is7A:
46.2
4yvxA-2is7A:
48.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U63_A_ACTA406_0
(THIOREDOXIN
REDUCTASE)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
3 / 3 HIS A 187
SER A 210
ARG A 217
None
NAP  A 316 (-2.7A)
None
0.77A 5u63A-2is7A:
undetectable
5u63A-2is7A:
23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1F_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 6 LEU A 257
MET A 285
THR A 286
LEU A 289
None
0.96A 5x1fA-2is7A:
undetectable
5x1fJ-2is7A:
undetectable
5x1fA-2is7A:
19.46
5x1fJ-2is7A:
11.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XDQ_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 1
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 7 LEU A 257
MET A 285
THR A 286
LEU A 289
None
0.74A 5xdqN-2is7A:
undetectable
5xdqW-2is7A:
undetectable
5xdqN-2is7A:
19.46
5xdqW-2is7A:
11.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_K_EF2K501_1
(PROTEIN CEREBLON)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 7 HIS A 306
TRP A  79
PHE A 122
THR A 140
None
None
2CL  A 317 ( 4.9A)
None
1.47A 5yizk-2is7A:
undetectable
5yizt-2is7A:
0.0
5yizk-2is7A:
12.50
5yizt-2is7A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YIZ_Y_EF2Y501_1
(PROTEIN CEREBLON)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 7 THR A 140
HIS A 306
TRP A  79
PHE A 122
None
None
None
2CL  A 317 ( 4.9A)
1.47A 5yizG-2is7A:
0.0
5yizY-2is7A:
0.0
5yizG-2is7A:
12.50
5yizY-2is7A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_K_EF2K501_1
(PROTEIN CEREBLON)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 7 HIS A 306
TRP A  79
PHE A 122
THR A 140
None
None
2CL  A 317 ( 4.9A)
None
1.47A 5yj0k-2is7A:
0.0
5yj0t-2is7A:
0.0
5yj0k-2is7A:
12.50
5yj0t-2is7A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ0_Y_EF2Y501_1
(PROTEIN CEREBLON)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 7 THR A 140
HIS A 306
TRP A  79
PHE A 122
None
None
None
2CL  A 317 ( 4.9A)
1.48A 5yj0G-2is7A:
0.0
5yj0Y-2is7A:
0.0
5yj0G-2is7A:
12.50
5yj0Y-2is7A:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ1_K_6ELK501_0
(PROTEIN CEREBLON)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 7 HIS A 306
TRP A  79
PHE A 122
THR A 140
None
None
2CL  A 317 ( 4.9A)
None
1.47A 5yj1k-2is7A:
0.0
5yj1t-2is7A:
undetectable
5yj1k-2is7A:
15.11
5yj1t-2is7A:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YJ1_Y_6ELY501_0
(PROTEIN CEREBLON)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 7 THR A 140
HIS A 306
TRP A  79
PHE A 122
None
None
None
2CL  A 317 ( 4.9A)
1.48A 5yj1G-2is7A:
undetectable
5yj1Y-2is7A:
undetectable
5yj1G-2is7A:
15.11
5yj1Y-2is7A:
15.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YVN_A_ACTA305_0
(GLUTATHIONE
S-TRANSFERASE
OMEGA-1)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 6 LEU A  62
GLN A  59
LEU A  99
LEU A 101
None
1.05A 5yvnA-2is7A:
undetectable
5yvnA-2is7A:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJZ_B_GMJB301_1
(SIGMA NON-OPIOID
INTRACELLULAR
RECEPTOR 1)
2is7 ALDOSE REDUCTASE
(Homo
sapiens)
4 / 6 TYR A 107
GLN A 183
GLU A  51
ALA A  91
None
NAP  A 316 (-3.7A)
None
None
1.26A 6djzB-2is7A:
undetectable
6djzB-2is7A:
22.76